Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model.
about
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment.Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease.A Metal-Free Method for Producing MRI Contrast at Amyloid-β.Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.Cholinesterases and the fine line between poison and remedy.
P2860
Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Reduced fibrillar β-amyloid in ...... Alzheimer disease mouse model.
@en
Reduced fibrillar β-amyloid in ...... Alzheimer disease mouse model.
@nl
type
label
Reduced fibrillar β-amyloid in ...... Alzheimer disease mouse model.
@en
Reduced fibrillar β-amyloid in ...... Alzheimer disease mouse model.
@nl
prefLabel
Reduced fibrillar β-amyloid in ...... Alzheimer disease mouse model.
@en
Reduced fibrillar β-amyloid in ...... Alzheimer disease mouse model.
@nl
P1476
Reduced fibrillar β-amyloid in ...... Alzheimer disease mouse model.
@en
P2093
P304
P356
10.1016/J.CBI.2016.04.022
P577
2016-04-15T00:00:00Z